| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| GSK is making significant advancements in product and service development, particularly with a focus on innovative therapies for critical healthcare needs. The company's commitment to RNA therapies and drug development for pulmonary hypertension, especially with the investigational drug HS235, indicates a proactive approach to addressing major health challenges. Additionally, GSK's interest in biopharmaceuticals showcases its dedication to exploring new therapeutic avenues. Overall, these initiatives reflect a robust pipeline aimed at delivering impactful health solutions. |
| The price action of GSK plc (GSK) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 0.2 is modestly bullish. The market sentiment at 1 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. GSK is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.1, and the negative at -0.1 on 2026-02-25. The forces of Sentiment towards Fundamentals (4.5), Option Sentiment (1.5), Stock Price Trend (0.2), Market Risk Appetite (0.1), and Price Level Sentiment (0) will drive up the price. The forces of Sector Price Trend (-0.1), and Valuation Sentiment (-0.5) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| GSK | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | 0%(0%) | 59.54 | 5.91% | 65 | 0.7% | 0% | 0.2 | 0 | 0.4% | 1 | Long | 55% | 4.5 | 6.5 |
| 2026-02-24 | 0%(0%) | 59.13 | 6.38% | 64 | -0.24% | 0% | 0.2 | 0 | 0.3% | 0.3 | Long | 55% | 4.2 | -1 |
| 2026-02-23 | 0%(0%) | 59.27 | 6.75% | 67 | -0.45% | 0% | 0.9 | 0 | 0.8% | 0.5 | Long | 55% | 3.8 | -1 |
| 2026-02-22 | 0%(0%) | 1.4 | 0 | 1.1 | 3.2 | -1 | ||||||||
| 2026-02-21 | 0%(0%) | 1.4 | 0 | 1.1 | 3.2 | -1 | ||||||||
| 2026-02-20 | 0%(0%) | 59.53 | 7.16% | 70 | -2.18% | 0% | 1.4 | -0.2 | 1% | 1.9 | Wait | 50% | 3.7 | -1 |
| 2026-02-19 | 0%(0%) | 60.86 | 7.34% | 80 | -0.56% | 0.68% | 2.6 | 0 | 1% | 1.6 | Long | 65% | 3.7 | -1 |
| 2026-02-18 | 0%(0%) | 61.2 | 7.48% | 84 | 0.53% | 1.2% | 3.4 | 0 | 1% | 1.4 | Long | 65% | 4.1 | -1 |
| 2026-02-17 | 0%(0%) | 60.87 | 7.54% | 86 | 3.29% | 1.56% | 3.2 | 0 | 1% | 1.9 | Long | 65% | 3.9 | -1 |
| 2026-02-16 | 0%(0%) | 1.8 | 0 | 2.1 | 4.6 | -1 | ||||||||
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| 2026-02-25 17:50:49 This theme focuses on the innovation and growth in the biopharmaceutical sector, highlighted by GSK's interest in protein-based therapeutics. |
| 2026-02-25 17:50:49 The theme represents GSK's strategic move to strengthen its portfolio through the acquisition of 35Pharma. |
| 2026-02-25 17:15:41 The announcement of GSK's acquisition and its implications for future revenues can positively influence stock performance, as reflected in market activity. |
| 2026-02-25 17:15:41 The acquisition includes a focus on a drug designed to avoid the bleeding risk associated with existing treatments, giving GSK a competitive edge in the market. |
| 2026-02-25 17:15:41 The anticipated market for pulmonary hypertension therapies is projected to reach $18 billion by 2032, suggesting strong growth potential and opportunities for GSK's new drug pipeline. |
| 2026-02-25 17:15:41 The focus on developing HS235, a potential investigational drug for pulmonary hypertension, indicates a commitment to innovate in addressing health issues related to obesity and heart failure. |
| 2026-02-25 17:15:41 GSK's acquisition of Canadian biopharmaceutical company 35Pharma for $950 million highlights a strategic investment aimed at expanding its drug offerings in the pulmonary hypertension market. |
| 2026-02-25 09:36:34 The introduction of HS235 targets a significant healthcare need, reflecting a commitment to innovative drug development. |
| 2026-02-25 09:36:34 GSK's acquisition of 35Pharma signifies a strategic investment to enhance their drug pipeline. |